0:00 Welcome to Uncle Life Center podcast. 0:02 Um, I want you to imagine walking into a clinic with a broken arm. 0:05 Okay. 0:06 And the doctor sits down and tells you that treating the left side of your bone requires a completely different strategy than treating the right side of the bone. 0:15 I mean, that sounds absurd. 0:16 It sounds completely absurd. 0:17 If a bone is a bone, you would naturally assume a fracture is a fracture. 0:22 But today, for this deep dive, we are looking at a fascinating stack of medical research that, well, it really challenges our most basic assumptions about disease. 0:30 Aaron Powell It does. 0:31 It forces us to ask whether the physical geographic location of a tumor in the colon completely changes the nature of the condition itself. 0:41 So when it comes to cancer of the colon and rectum, assuming that a single organ means you are dealing with a single uniform disease is fundamentally flawed. 0:50 Trevor Burrus, Jr. 0:50 Deeply flawed. 0:51 We are going to unpack data today showing you that a tumor on the right side of this organ and a tumor on the left side are at a biological level entirely different diseases. 1:01 They are operating under completely different rule books. 1:05 Because the geography of where a tumor originates is it's far more than just anatomical trivia. 1:10 It's actually a story of embryonic blueprints. 1:13 Which is wild to think about. 1:15 It is. 1:17 Think about this for a second. 1:18 The way a tumor behaves, or how it responds to treatment, and even how it hides in your body when you're 60 years old, that was literally predetermined by how your gut folded together when you were just a three-week-old embryo. 1:32 So your cancer's biological rule book was written long before you even had a heartbeat. 1:37 That's the reality the data is showing us. 1:39 Okay. 1:39 Let's unpack this from the very beginning. 1:42 Because to understand the disease, we first need to understand why doctors even split a single continuous organ into two halves in the first place. 1:49 Sure. 1:49 I mean, if you look at an anatomical diagram, the colon is just one long tube framing the abdomen. 1:55 It loops up, goes across, and goes down. 1:57 So why draw an invisible line down the middle and treat these halves as separate entities? 2:01 Aaron Powell Well, we map the colon out based on its functional development, not just its mature shape. 2:07 So the right side begins exactly where your small intestine ends. 2:10 Okay. 2:10 It includes the cecum, which is the pouch at the very beginning of the large intestine. 2:14 Then the ascending colon that travels straight up the right side of your abdomen, and the first half of the transverse colon crossing over the top. 2:21 Aaron Powell And then the left side just picks up from that midpoint. 2:24 Exactly, from that midpoint. 2:25 Okay. 2:26 It includes the splenic flexure near your spleen, the descending colon traveling down the left side, the sigmoid colon, and finally the rectum. 2:34 Aaron Powell And I noticed in the research that most clinical research groups rectal cancer with the left side because they share identical origins. 2:41 Aaron Powell Yes, though surgeons sometimes treat the rectum as a distinct category simply due to the incredibly tight physical space down in the pelvis, but biologically it aligns with the left. 2:51 Aaron Powell So we have this continuous tube, but you're saying the physical split matters because of how it was built in the womb. 2:57 Why does the split actually change anything for a patient sitting in an oncology clinic decades later? 3:02 Aaron Powell Because the two halves literally develop from completely different embryonic tissue. 3:06 In a developing embryo, the right side forms from a structure called the mid-gut. 3:11 Aaron Powell While the left side forms from an entirely separate structure called the hind gut? 3:15 Yes. 3:15 And because they originate from totally different starting materials, they develop entirely different blood supplies. 3:21 The right side is fed by the superior mesenteric artery, while the left side is fed by the inferior mesenteric artery. 3:28 Aaron Powell So they are cultivating different local chemical environments from day one. 3:32 Aaron Powell Completely different environments. 3:34 Even the colonies of microscopic gut bacteria living on the right side differ dramatically from the bacteria colonizing the left side. 3:41 Aaron Powell And the statistics from the research really highlight how this plays out in the real world. 3:45 For you listening, left-sided tumors are the more common of the two. 3:49 They make up about six in ten cases. 3:51 Aaron Ross Powell But right-sided cases still make up a very significant four in ten. 3:56 So we aren't talking about some rare anomaly on the right side. 3:59 We're talking about 40% of the patient population facing a disease that operates under different biological rules than the majority. 4:06 And because the physical environment of these two sides is so distinctly different, the way the cancer actually announces itself to the patient is entirely different as well. 4:15 The symptoms are heavily dictated by the local terrain. 4:19 I think the best way to visualize this terrain is to think of the colon like a changing pipeline. 4:23 Aaron Powell That's a good way to look at it. 4:25 On the right side, at the beginning of the journey, think of the pipe like a wide rushing river. 4:30 The material passing through it, the digestive waste entering from the small intestine, is mostly liquid. 4:35 But as you move along that pipeline toward the left side, the pipe functions more like a narrow garden hose. 4:41 The space gets much tighter and the material inside becomes solid and firm as water is absorbed back into the body. 4:48 Applying that changing pipeline dynamic to the data explains the vast difference in symptom presentation. 4:54 On the right side, because the space is wide, like that river, and the contents are fluid, a tumor has a massive amount of room to grow. 5:02 It can expand significantly without causing any mechanical blockage. 5:06 Aaron Powell Because the fluid just flows right around the mass. 5:08 We call these the silent growers. 5:11 Patients with right-sided tumors often experience symptoms that are incredibly vague. 5:15 Like what kind of symptoms? 5:17 They might feel unusual lingering fatigue. 5:19 They often develop unexplained anemia, and that happens because the tumor slowly ulcerates and bleeds microscopically into the digestive tract over months. 5:27 Aaron Powell So the blood is completely invisible to the naked eye. 5:31 It is. 5:32 But the constant iron depletion leaves the patient exhausted. 5:35 They might experience unexplained weight loss or just a vague, dull ache low on the right side of the abdomen. 5:41 Aaron Ross Powell Those symptoms are so incredibly general, though. 5:44 I mean, if you are experiencing fatigue and a vague ache, you might just think you are working too hard. 5:50 Or maybe you pulled a muscle at the gym. 5:52 Or you're simply feeling your age. 5:54 Aaron Powell You wouldn't immediately suspect a growing tumor. 5:57 Conversely, because the left side is a narrow space carrying firmer material, even a very small tumor disrupts the flow quickly. 6:05 Like if a pebble gets lodged in a narrow garden hose, the pressure builds up immediately. 6:10 And so the symptoms on the left side function like early alarm bells. 6:14 Patients will notice uh visible red blood. 6:17 They might see narrower stools because the solid material is being forcibly squeezed past a physical obstruction. 6:25 They experience intense cramping, bloating, and a very noticeable sudden change in their daily bowel habits. 6:30 Aaron Powell Which means left-sided disease is often caught much sooner, simply because the symptoms force the patient to go see a doctor. 6:37 You can't ignore visible blood or a severe blockage. 6:41 This is exactly why routine screening for the listener is incredibly vital, because if a patient waits until they actually feel unwell, a right-sided tumor might have been growing silently for years in that wider space, slowly depleting their iron. 6:55 Aaron Powell Screening protocols like colonoscopies exist precisely to find those silent right-sided tumors before the vague symptoms ever have a chance to appear. 7:03 But the physical space and the symptoms are just the visible tip of the iceberg. 7:08 When we take tissue from both sides and look at it under a microscope, we see that the tumors diverge completely at the level of DNA and cellular behavior. 7:17 The genetic blueprints of the tumors are distinct based entirely on their geographic location. 7:22 Aaron Powell So if the physical shape of the pipe explains why right-sided tumors hide so well, once we actually find them and look at them under a microscope, do they at least look the same? 7:32 The data suggests they absolutely do not. 7:34 They don't. 7:35 Let's look closely at the microscopic blueprints, maybe starting with the right side. 7:39 Right-sided tumors have a much higher rate of something called mismatch repair gene changes. 7:44 You'll often see this abbreviated in the literature as MSI. 7:47 Aaron Powell And to understand what this means, I mean, think of how your cells divide. 7:51 Every time a cell divides, it has to copy its DNA, which is millions of lines of code. 7:57 Mistakes naturally happen during this copying process. 7:59 Aaron Powell Normally your cells have a built-in mechanism, a chemical spell checker, to fix those errors instantly. 8:05 But in these right-sided tumors, that repair mechanism is physically broken. 8:10 Aaron Powell Because the spell checker is offline. 8:12 So genetic typos pile up exponentially every single time the cell divides, creating a wildly mutated, unstable tumor. 8:20 Aaron Powell The research also points out that right-sided tumors often feature poorly differentiated cells. 8:26 What does that actually look like to a pathologist staring down a microscope? 8:30 Aaron Powell Well, normally colon cells have a highly specialized, orderly, microscopic structure. 8:35 They have a specific shape designed to absorb water and secrete mucus. 8:39 So poorly differentiated means the cancer cells have devolved and lost that specialized structure entirely. 8:46 They no longer look like colon cells at all. 8:48 They look like chaotic, shapeless blobs that only know how to do one single thing, divide and multiply. 8:55 This lack of differentiation is a strong biological signal of aggressive, fast-paced growth. 9:01 Additionally, right-sided tumors carry a higher rate of BRAF mutations, which is an alteration in a specific gene that acts like a stuck gas pedal, constantly telling the cell to grow and divide. 9:12 And the research also heavily links right-sided colon cancer to Lynch syndrome. 9:16 Right, which is an inherited genetic condition that significantly raises a person's lifetime risk of developing colorectal cancer. 9:23 And it has a very strong preference for appearing on the right side, often in much younger patients. 9:28 So that is the genetic profile of the right side. 9:32 You have broken DNA repair, chaotic cells, and stuck gas pedals. 9:36 How does the left side compare to this? 9:38 Because we know that colorectal cancer in patients under the age of 50 generally favors the left side, assuming Lynch syndrome is not a factor. 9:46 Trevor Burrus, Jr. 9:46 Left-sided tumors present a fundamentally different genetic landscape. 9:50 They are far less likely to show those mismatch repair or MSI changes. 9:55 So their DNA spell checker is usually still intact. 9:58 Yes. 9:58 So they do not have that massive chaotic accumulation of DNA errors. 10:03 However, they frequently carry entirely different mutations, specifically in a family of genes called RAS. 10:09 Aaron Powell And what makes this critical is that many of these specific left-sided mutations rely on very well-defined cellular pathways to grow. 10:17 Aaron Powell And because those pathways are so well-defined, modern medicine has been able to develop highly effective, targeted therapies designed to block those exact pathways. 10:27 So what does this all mean? 10:29 If the right side is characterized by poorly differentiated cells, rapid mutation accumulation, and silent, undetected growth, it is very easy to look at this data and conclude that right-sided cancer is just universally a worse diagnosis. 10:44 It is a common assumption. 10:45 But I want to push back on that and look closely at the survival data because we cannot flatten this into a simple narrative of the right side is always worse. 10:53 The reality changes dramatically depending on the stage of the disease. 11:13 The landmark CALGB SWAG 8405 trial brought this into sharp focus for the medical community. 11:19 It did. 11:20 In stage four, right-sided tumors are unequivocally linked to lower survival rates and higher mortality rates compared to left-sided tumors. 11:28 I was looking at the notes on that CALGB trial, and the survival gap in stage four looks massive. 11:35 Is that a real proven biological difference, or could it just be a statistical fluke based on the specific patients they studied? 11:42 Aaron Powell The researchers proved it is a real biological difference. 11:45 They measured it rigorously using a statistical tool called a hazard ratio to compare the mortality risk between the two groups. 11:53 And crucially, they reported this with a narrow 95% confidence interval. 11:57 Aaron Powell Which for the listener means when researchers report a narrow confidence interval that excludes the number one, they are mathematically highly confident that the difference in survival is not a fluke or a random grouping of data. 12:11 Aaron Powell The underlying biological difference between the mid-gut and hindgut origins is undeniably driving that survival gap in advanced stage four disease. 12:19 Aaron Powell But then we encounter the nuance of the early stage data. 12:23 There is a major SEER registry study, which is a massive national database tracking cancer incidence and survival that looked at the earlier stages of the disease. 12:33 And when the researchers adjusted for other patient factors like age and overall health, right-sided tumors actually showed better overall survival in stages one and two compared to left-sided tumors. 12:44 Yes. 12:45 Better survival on the right in early stages. 12:47 Wait, hold on. 12:48 You just told me that right-sided tumors have broken DNA repair kits, chaotic, poorly differentiated cells, and silent growth. 12:56 How on earth does that translate to a better survival rate in stages one and two? 13:01 That feels completely backwards to everything we just discussed. 13:04 Aaron Powell It highlights the sheer complexity of tumor biology. 13:07 And it is exactly why researchers constantly debate this topic. 13:11 The theory is that in the very early stages, that massive accumulation of DNA errors, the broken spell check, actually makes the tumor so strange and highly mutated that the patient's own immune system can easily recognize it as a threat and help keep it in check. 13:28 Oh, I see. 13:29 But we see a convergence point as the disease progresses. 13:33 We do. 13:34 That right-sided survival advantage present in stages one and two narrows and completely disappears by stage three. 13:41 So by the time the cancer overcomes the immune system and transitions into stage four, the dynamic fully reverses. 13:48 The mutations that once flagged the tumor to the immune system now fuel its aggressive spread. 13:54 And the right side becomes a distinct survival disadvantage. 13:57 This shifting landscape of survival rates is incredible. 14:00 I mean, it isn't a static situation where one side is just the bad side. 14:05 The behavior of the disease evolves as it grows. 14:08 It's highly dynamic. 14:09 Given this incredibly complex web of survival data, shifting stage differences, and unique genetic mutations, how do medical teams actually build a treatment plan? 14:19 You obviously cannot treat this disease as a monolith. 14:22 The approach must change drastically depending on both the stage of the cancer and its geographic origin. 14:27 For earlier localized stages, those stage one and stage two tumors on either side, surgery remains the standard, foundational treatment. 14:35 The primary goal is to physically remove the diseased section of the colon and the surrounding lymph nodes. 14:41 The surgical technique differs depending on the blood supply we discussed earlier, but the intent is the same. 14:47 However, once the disease is advanced, the physical location and the precise genetic profile must be used together to decide between targeted therapy and systemic chemotherapy. 14:58 So this genetic testing doesn't just happen as an afterthought. 15:01 It happens immediately. 15:03 Upon diagnosis, the medical team runs a comprehensive molecular panel on the tumor tissue obtained from the biopsy. 15:08 Aaron Powell They test for the mismatch repair status we discussed. 15:12 They look for those RAS mutations and the BRAF status right at diagnosis. 15:16 Aaron Powell And the results of those genetic tests, combined with the knowledge of whether the tumor originated on the left or the right side, dictate the entire medical strategy. 15:25 Aaron Powell For example, if a patient has an advanced left-sided tumor with specific RAS mutations, the team knows that targeted therapies designed to block those pathways are highly likely to be effective. 15:38 Conversely, if a patient has an advanced right-sided tumor with mismatch repair changes, traditional chemotherapy might be less effective. 15:46 Instead, the team might pivot toward immunotherapies. 15:49 Because those right-sided tumors have so many mutations, immunotherapy drugs can essentially take the brakes off the patient's own immune system, allowing it to recognize and attack those heavily mutated cells with incredible precision. 16:02 This level of customization requires a massive collaborative effort. 16:06 This isn't just a single doctor looking at a chart, guessing based on a textbook and writing a prescription. 16:12 It requires a dedicated, multidisciplinary team, usually meeting in what is called a tumor board. 16:18 You have medical oncologists who deeply understand the systemic drugs and immunotherapy pathways. 16:23 You have surgeons who understand the anatomical challenges of navigating the superior versus the inferior mesenteric blood vessel networks. 16:30 You have pathologists who are analyzing the cellular differentiation and genetic sequencing under the microscope. 16:36 They all sit down together in one room, review the tumor location, and cross-reference it with the genetic profile to catch the nuanced details that a single specialist working in isolation might easily miss. 16:46 The treatment plan has to fit the specific biological reality of the cancer, not just its stage on paper. 16:52 The entire modern paradigm of colorectal oncology relies on acknowledging that a tumor in the ascending colon on the right and a tumor in the descending colon on the left are operating from completely different rulebooks. 17:04 So to synthesize this for the listener, the core insight to take away today is that this disease defies simple categorization. 17:12 It really does. 17:13 Its behavior, the physical symptoms it causes, and the way it responds to cutting-edge treatments are deeply, intrinsically tied to its geographic origin in the body. 17:21 You cannot separate the location from the disease itself. 17:24 It leaves us with a truly fascinating concept to consider as we wrap up. 17:28 Think about the profound interconnectedness of human biology. 17:32 Clues from our very first days of embryonic development, when the mid-gut and hindgut were just beginning to form weeks after conception, ultimately hold the key to how our bodies will respond to advanced, highly targeted cancer treatments decades later in life. 17:45 It's amazing that our biological beginnings echo all the way to the end. 17:50 Thank you for joining this deep dive into the underlying biology of this complex disease. 17:55 Keep questioning the world around you. 17:58 Keep looking past the surface of the data, and we will catch you on the next deep dive.
Community discussion